Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate spray versus lidocaine spray for hemodynamic responses to laryngoscopy
IRCT20230719058846N1Phase 2Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of magnesium sulfate and lidocaine (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Heart rate change after laryngoscopy, Blood pressure change after laryngoscopy and 1 more. Started Nov 2023; status: completed.
02
Drugs
magnesium sulfatelidocaine
Beyond the preview
Go deeper on IRCT20230719058846N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230719058846N1.